Viewing Study NCT06568367


Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2026-01-05 @ 11:07 PM
Study NCT ID: NCT06568367
Status: RECRUITING
Last Update Posted: 2025-11-25
First Post: 2024-08-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
Sponsor: Axsome Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module